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methods
Synthesis and characterization of diazirine alkyne probes
for the study of intracellular cholesterol trafficking
McKenna Feltes,* Samantha Moores,* Sarah E. Gale,* Kathiresan Krishnan,†
Laurel Mydock-McGrane,† Douglas F. Covey,† Daniel S. Ory,1,* and Jean E. Schaffer*,†
Departments of Medicine* and Developmental Biology,† Washington University School of Medicine,
St. Louis, MO 63110

Supplementary key words lipids • lipoproteins • metabolism • biorthogonal probes • regulation

Cholesterol is an essential structural component of
cellular membranes that regulates the membrane fluidity
and permeability of phospholipid bilayers and the functions
of integral membrane proteins. In addition, cholesterol serves
as a precursor molecule for oxysterol, bile acid, and hormone
synthesis. The distribution of cholesterol among cellular membranes is heterogeneous. The plasma membrane contains
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60% to 70% of total cellular cholesterol at a concentration
of 40 mol% (1, 2). In contrast, the ER and mitochondria
are cholesterol-poor, with 1% of total cellular cholesterol
in the ER, where its concentration is <5 mol% (1, 3). The
low cholesterol content of the ER and its proximity to the
cholesterol synthesis machinery facilitate sensitive monitoring of cellular cholesterol levels and tight regulation of uptake and synthesis. The ER-resident SREBP2 transcription
factor serves as the primary regulatory axis for cholesterol
homeostasis. When ER is cholesterol-depleted, membranebound SREBP2 traffics from the ER to the Golgi, where
proteolytic processing liberates the soluble, mature transcription factor, which then translocates to the nucleus
to upregulate genes involved in cholesterol synthesis and
uptake. When the ER is cholesterol replete, SREBP2 is
retained in the ER. The ER-resident protein ACAT converts
excess sterol to cholesteryl esters for storage in lipid droplets (4). Excess cholesterol also promotes the conversion of
cholesterol to oxysterols in the mitochondria, activating
LXR, which upregulates the expression of genes involved
in cholesterol efflux (5). The asymmetric distribution of
cholesterol within and across different cellular membranes
is critical in these regulatory mechanisms and persists
despite the rapid flux of cholesterol between surface and
internal pools (6).
Mammalian cells acquire cholesterol through the uptake
of cholesterol and cholesteryl ester-laden lipoprotein particles by receptor-mediated endocytosis or through de novo
synthesis in the ER (7). The bulk distribution of endocytosed, LDL-derived cholesterol and cholesteryl esters depends on the lysosomal proteins Niemann-Pick C (NPC) 1
and 2, as well as lysosomal acid lipase (LAL). LDL-derived
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ovary; HA, human influenza hemagglutinin; HMGCS, HMG-CoA synthase; LAL, lysosomal acid lipase; LALi, lalistat; LPDM, lipoproteindeficient media; NPC, Niemann-Pick C; qPCR, quantitative PCR; Rplp0,
ribosomal protein lateral stalk subunit P0; SRA, scavenger receptor A;
THPTA, tris-hydroxypropyltriazolylmethylamine; VAMP7, vesicle-associated membrane protein 7.
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Abstract Cholesterol is an essential structural component of
cellular membranes and precursor molecule for oxysterol, bile
acid, and hormone synthesis. The study of intracellular cholesterol trafficking pathways has been limited in part due to a lack
of suitable cholesterol analogues. Herein, we developed three
novel diazirine alkyne cholesterol probes: LKM38, KK174, and
KK175. We evaluated these probes as well as a previously described diazirine alkyne cholesterol analogue, trans-sterol, for
their fidelity as cholesterol mimics and for study of cholesterol
trafficking. LKM38 emerged as a promising cholesterol mimic
because it both sustained the growth of cholesterol-auxotrophic
cells and appropriately regulated key cholesterol homeostatic
pathways. When presented as an ester in lipoprotein particles,
LKM38 initially localized to the lysosome and subsequently
trafficked to the plasma membrane and endoplasmic reticulum. LKM38 bound to diverse, established cholesterol binding
proteins. Through a detailed characterization of the cellular
behavior of a panel of diazirine alkyne probes using cell biological, biochemical trafficking assays and immunofluorescence approaches, we conclude that LKM38 can serve as a
powerful tool for the study of cholesterol protein interactions
and trafficking.—Feltes, M., S. Moores, S. E. Gale, K. Krishnan,
L. Mydock-McGrane, D. F. Covey, D. S. Ory, and J. E. Schaffer.
Synthesis and characterization of diazirine alkyne probes for
the study of intracellular cholesterol trafficking. J. Lipid Res.
2019. 60: 707–716.
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MATERIALS AND METHODS
Chemicals and reagents
With the exception of McCoy’s medium (Gibco), sodium bicarbonate (Corning), and GlutaMAX (Promega), all cell culture
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reagents as well as methyl--cyclodextrin, CuSO4, tris-hydroxypropyltriazolylmethylamine (THPTA), ascorbic acid, BSA, SDS, glutaraldehyde, cholesterol oxidase, sphingomyelinase, nicotinic
acid, O-[2-(1-azepanyl)ethyl]hydroxylamine dihydrocholoride,
and PMSF were obtained from MilliporeSigma. Lipoproteindeficient serum was prepared from FBS in-house using Cab-O-Sil
(Supelco Analytical) (18). Lalistat (LALi) was a gift from the
Maxfield Laboratory (compound 13) (19). Cholesterol was from
Steraloids. Acetylated LDL (acLDL) was from Alfa Aesar. The
commercially available deuterated compounds used in this study
included d7-cholesteryl oleate (Avanti Polar Lipids), d5-cholesterol
(Medical Isotopes, Inc.), and d5-cholestenone (CDN Isotopes).
d17-Oleic acid (Cayman Chemical) and d4-cholesterol (Cambridge
Isotope Laboratories) were used for the synthesis of d17-LKM38
oleate and d4-cholesteryl oleate standards, respectively. Additional reagents included methanol (JT Baker), chloroform (BDH
VWR Analytical), and formic acid (Acros Organics).

Diazirine alkyne probes
The trans-sterol probe was made in-house using a previously
published synthesis (15). The synthesis of LKM38 and KK174
have previously been reported (16, 17). The synthesis of KK175
and LKM38 oleate as well as LKM38-one, d17-LKM38 oleate, and
d4-cholesteryl oleate standards are detailed in the supplemental
Methods online. Diazirine alkyne probe stocks were prepared at
10 µM in ethanol unless otherwise stated.

Cell culture
U2OS cells expressing the human scavenger receptor A (SRA)
were obtained from the Maxfield Laboratory (20). Chinese hamster ovary (CHO) cells expressing human influenza hemagglutinin
(HA) epitope-tagged NPC2 were generated by the transduction of
CHO cells with a retroviral construct expressing NPC2-HA (21,
22). Human skin fibroblasts were obtained from ATCC, and
CYP27A1-deficient CTX-205-5 fibroblasts were a gift from Eran
Leitersdorf (23). U2OS-SRA cells were cultured in McCoy’s medium containing 10% FBS, 1.2 g/l sodium bicarbonate, and 1 mg/
ml G418. CHO cells were cultured in DMEM-F12 (1:1) containing
5% FBS, 0.5 mM sodium pyruvate, and 2 mM l-glutamine. Human
fibroblasts were cultured in DMEM containing 10% FBS and
1× GlutaMAX. Lipoprotein-deficient medium (LPDM) contained
lipoprotein-depleted FBS instead of regular serum. Starvation
media were prepared by adding 20 µM lovastatin and 50 µM
mevalonate to LPDM.

Cell viability assay
U2OS-SRA cells were seeded at 3,000 cells/well in 96-well plates
overnight before being subjected to a 15 min pulse of 0.5%
methyl--cyclodextrin in LPDM to deplete cellular cholesterol.
Cells were then treated with starvation media containing 10 µM
cholesterol, LKM38, KK174, KK175, trans-sterol, probe or vehicle.
After 72 h, cell viability was assayed using the CellTiter-Glo Luminescent Cell Viability Assay (Promega).

Microscopy
U2OS-SRA cells were grown on coverslips at 1.8 × 105 cells/well
in six-well dishes. Cells were incubated in LPDM containing
LKM38 oleate reconstituted acLDL (24) with or without 10 µM
LALi overnight. Media were spiked with 1 µM LysoTracker Red
DND-99 (Thermo Fisher Scientific) 2 h before fixation for 10 min
in 4% paraformaldehyde (Electron Microcopy Sciences). Coverslips were washed and then subjected to copper-catalyzed cycloaddition chemistry (click reaction). Cells were placed in 0.5 ml
Tris-buffered saline; 20 µl 50 mM CuSO4, 20 µl 10 mM THPTA,
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cholesterol and cholesteryl esters are delivered to late endosomes/lysosomes. Under acidic conditions, LAL cleaves
cholesteryl esters, liberating free cholesterol (7). Sequential
“hydrophobic handoffs” are proposed to facilitate the transfer of cholesterol to the limiting lysosomal membrane, the
first between the lipase and NPC2 and the second between
NPC2 and NPC1. NPC2, a small soluble protein localized to
the lysosomal lumen, binds cholesterol with the iso-octyl
side chain buried deep within its binding pocket (8). By
contrast, NPC1 is a large multidomain protein located in
the limiting membrane of late endosome/lysosomes. Its luminal N-terminal domain binds the 3-hydroxyl group of
cholesterol and is hypothesized to accept cholesterol from
NPC2 (9–11). Mutations in either NPC1 or NPC2 result in
dysregulated cholesterol homeostasis with the accumulation of unesterified cholesterol in the lysosomal compartment and impaired cholesterol reesterification (12).
The study of intracellular cholesterol trafficking pathways
is central to understanding homeostatic pathways as well as
disease pathogenesis. However, past approaches have been
limited in part due to a lack of suitable cholesterol probes.
Intrinsically fluorescent cholesterol analogues (dehydroergosterol and cholestatrienol) have weak fluorogenic
properties. Bulky fluorophore conjugates (BODIPY- and
NBD-cholesterol) fail to faithfully mimic cholesterol trafficking and membrane behavior (13, 14). Minimally modified
diazirine alkyne cholesterol probes provide a new approach
for the study of cholesterol trafficking. The alkyne functional
group enables copper-catalyzed azide alkyne cycloaddition
(“click chemistry”) of azide reporter molecules (e.g., fluorophores or biotin) after trafficking has taken place, while the
diazirine group enables UV-activated cross-linking of probes
to nearby biomolecules. A diazirine alkyne probe, transsterol, was recently used to identify the static cholesterol proteome (15). Several known cholesterol binding proteins such
as SREBP cleavage-activating protein and HMG-CoA reductase were identified, highlighting the utility of this approach.
Protein binding for two other diazirine alkyne cholesterol
probes, LKM38 and KK174, has been shown to be sensitive to
cholesterol competition (16, 17). Nonetheless, the extent to
which these cholesterol probes mimic the trafficking characteristics of native cholesterol and its behavior with respect to
the regulation of sterol homeostatic responses has yet to be
determined.
Herein, we studied diazirine alkyne cholesterol probes
LKM38, KK174, and trans-sterol probe, as well as a novel
probe, KK175, for their fidelity as cholesterol mimics and
use as dynamic cholesterol probes. Through detailed characterization of the cellular behavior of these diazirine alkyne
probes, we identified new tools for the study of intracellular
cholesterol trafficking.

Supplemental Material can be found at:
http://www.jlr.org/content/suppl/2019/01/07/jlr.D091470.DC1
.html

5 µl 10 mM fluorescein azide (Lumiprobe), and 20 µl 250 mM
ascorbic acid were added sequentially to each well and then incubated for 30 min while rocking in the dark. This was immediately
followed by a second, identical click reaction to maximize click
efficiency. Coverslips were washed for 5 min each with PBS containing 40 mg/ml BSA, 0.5 M NaCl, and PBS before mounting on
slides. Images were collected on a Nikon A1+ confocal microscope at 100× magnification (pixel size = 0.1 µm; Z-step size = 0.13
µm; optical resolution = 0.23 µm; optical sectioning = 0.42 µm).
Colocalization quantification was performed using ImageJ.

Gene expression

Biochemical trafficking assays
For esterification and cholestenone assays, cells were plated at
6 × 104 cells/well in 12-well dishes. After overnight incubation,
media were changed to LPDM supplemented with acLDL reconstituted with either LKM38 oleate or d7-cholesteryl oleate overnight in the presence of 10 µM LALi. Cells were chased in
LALi-free media for 0–12 h before harvest. For esterification experiments, d9-oleate/BSA (25) was included during the chase
period. For ester quantification, cellular lipids were extracted
in 9:1 methanol-chloroform at 20°C. d17-LKM38 oleate or d4cholesteryl oleate was added as an internal standard for LKM38
oleate or d7-cholesteryl oleate experiments, respectively. Cell lysate
was collected by scraping. Supernatant was collected after centrifugation, dried under nitrogen, and resuspended in 9:1 methanolchloroform. For the quantification of plasma membrane cholesterol, we used a cholesterol oxidase assay (26). In brief, cells were
fixed in 1% glutaraldehyde and then exposed to 0.1 U/ml sphingomyelinase and 2 U/ml cholesterol oxidase to convert surfaceaccessible cholesterol or LKM38 to cholestenone or LKM38-one,
respectively. Cellular lipids were extracted in 9:1 methanolchloroform, with d5-cholestenone added as an internal standard.
Extracts were dried under nitrogen, resuspended in 20 µl 0.05 M
O-[2-(1-azepanyl)ethyl]hydroxylamine dihydrocholoride and 10 µl
formic acid, and heated for 1 h at 50°C to derivatize cholestenones. LC/MS/MS was monitored in the positive mode for the
ion transitions of interest (supplemental Table S1).

Immunoprecipitation of probe complexes
Following the incubation in LPDM overnight, cells were pulselabeled for 1 h with 2.5 µM (for NPC1) or 10 µM [for NPC2, caveolin, and vesicle-associated membrane protein 7 (VAMP7)]
LKM38/methyl--cyclodextrin complexes diluted in McCoy’s medium with 0, 10, or 100× cholesterol/methyl--cyclodextrin as a

Fluorescent gel profiling
U2OS-SRA cells were treated with 10 M probe (in ethanol) in
culture media for 24 h. Media were changed to normal culture
media, LPDM, or LPDM containing 100 g/ml acLDL for 18 h.
Cross-linking, click reaction, SDS-PAGE, and imaging were performed as described above, except gels were methanol-fixed before imaging. Parallel samples were prepared for Western blot
analysis.

RESULTS
Characterization of diazirine alkyne probes
To develop tools for the study of cholesterol-protein interactions, we synthesized several novel cholesterol analogues. Each analogue contains a diazirine and alkyne
group to enable UV cross-linking and copper-catalyzed
cycloaddition, respectively. Probes were generated with
diazirine and alkyne groups at different positions in an
effort to survey the effect of these modifications on the
behavior of the molecule (Fig. 1). We also evaluated a previously described diazirine alkyne cholesterol analogue,
trans-sterol probe (15). In a stringent test of cholesterol
mimicry, we examined the ability of diazirine alkyne probes
to support the growth of cholesterol-auxotrophic cells
(Fig. 2A). KK174 and trans-sterol were cytotoxic, while KK175
was cytostatic. By contrast, LKM38 partially supported
auxotrophic cell growth, although not as robustly as cholesterol. Interestingly, alkyne-only probes supported growth
at levels nearly equivalent to cholesterol, suggesting the diazirine group is the modification that limits the ability of
the probes to support growth in the absence of cholesterol
(Fig. 2B).
Probes for intracellular cholesterol trafficking
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U2OS-SRA cells or CTX-205-5 (CYP27A1-deficient) cells were
plated at 4 × 105 or 2 × 105, respectively, in 6 cm dishes and grown
overnight before incubation with starvation media containing 10
µM cholesterol, LKM38, KK174, KK175, trans-sterol, or vehicle
(ethanol) for 14 h. After washing, RNA was collected in Trizol
(Ambion) and prepared for quantitative PCR (qPCR) using the
SuperScript III First-Strand Kit (Invitrogen). Relative RNA
amount was determined by qPCR using PerfeCTa SYBR green
FastMix (QuantaBio) and primers (IDT) to HMG-CoA synthase
(HMGCS) (forward: GAT GTG GGA ATT GTT GCC CTT; reverse: ATT GTC TCT GTT CCA ACT TCC AG), ABCA1 (forward:
TTC CCG CAT TAT CTG GAA AGC; reverse: CAA GGT CCA
TTT CTT GGC TGT), and ribosomal protein lateral stalk subunit
P0 (Rplp0) (forward: GGA GAC GGA TTA CAC CTT CCC; reverse: CAG CCA CAA AGG CAG ATG G). Relative quantification
of target transcript abundance was calculated with the ddCT
method using Rplp0 as an endogenous control on an ABI 7500
Fast Real-Time PCR system.

competitor. LKM38 and cholesterol methyl--cyclodextrin
complexes were prepared in a ratio of 2.5 mM methyl-cyclodextrin/250 µM sterol and then sterile-filtered. The amount
of cholesterol recovered in the cyclodextrin solution was determined by MS. Cells were washed with PBS before being subjected
to UV cross-linking (366 nm) by UV Stratalinker 1800 (Stratagene) for 5 min on ice. Cells were collected by scraping in RIPA
lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium
deoxycholate) containing 1 mM PMSF and EDTA-free Protease
Complete (Roche), sonicated, and incubated for 1 h while rotating at 4°C. Lysates were spun at 16,000 g for 10 min at 4°C, and
supernatants were collected and analyzed for protein content by
BCA (Thermo Fisher Scientific). Equal amounts of protein were
added to Protein A Dynabeads (Novex) loaded with the appropriate antibody. After immunoprecipitation, beads were washed and
subjected to click reaction. Beads were resuspended in 50 µl RIPA
lysis buffer before the sequential addition of 1 µl 50 mM CuSO4, 1
µl 5 mM THPTA, 0.5 µl 10 mM rhodamine X azide (Lumiprobe),
and 1 µl 250 mM ascorbic acid. The mixture was incubated for 30
min at 37°C while shaking at 1,100 rpm in the dark. Beads were
washed in lysis buffer, suspended in 1× Laemmli sample buffer,
and incubated for 10 min at 37°C before loading on 4% to 12%
precast Bis-Tris gels (Invitrogen) for SDS-PAGE. Fluorescent images of gels were collected by a Typhoon scanner at 100 µm resolution. After imaging, gels were transferred to nitrocellulose and
then probed for the appropriate target by Western blotting. Immunoprecipitation and Western blotting antibody conditions are
provided in supplemental Table S2.

Supplemental Material can be found at:
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Fig. 1. Diazirine alkyne cholesterol probes. Cholesterol (A), LKM38 (B), KK174 (C), KK175 (D), transsterol (E), and LKM38 oleate (F).

diazirine alkyne probes suppressed HMGCS expression to
a similar degree as cholesterol (Fig. 3A). To monitor for
possible off-target oxysterol effects, the expression of
ABCA1, an LXR target, was determined. Neither cholesterol, LKM38, nor trans-sterol significantly increased
ABCA1 expression (Fig. 3B). In contrast, the diazirine alkyne probes KK174 and KK175 increased ABCA1 expression. When this experiment was performed in cells deficient
in CYP27A1, a mitochondrial enzyme responsible for

Fig. 2. Growth of cholesterol-auxotrophic cells in the presence of diazirine alkyne probes. U2OS-SRA cells
were pulsed for 15 min with 0.5% methyl--cyclodextrin in LPDM and treated for 72 h in starvation media
containing 10 M cholesterol, diazirine alkyne (A), or alkyne without diazirine (B) in ethanol. Cell viability
was assessed using the CellTiter-Glo assay. Values are normalized to cholesterol-treated cells. Bars: mean +
SEM. Each experiment was performed in quadruplicate, n = 3. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P <
0.05 for compound versus vehicle, and $P < 0.001 for compound or vehicle versus cholesterol using one-way
ANOVA followed by Dunnett’s test.
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Effects of diazirine alkyne probes on the regulation of
sterol homeostatic responses
To assess the ability of diazirine alkyne probes to serve as
authentic cholesterol mimics, we tested their capacity to
regulate SREBP2 target gene expression, an important sterol homeostatic response that governs de novo cholesterol
synthesis. Transcript levels of HMGCS, an SREBP2 target,
were monitored after 14 h in the presence of cholesterol or
diazirine alkyne probe as the only provided sterol. All

Supplemental Material can be found at:
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synthesizing the endogenous LXR ligand 27-hydroxycholesterol, similar suppression of HMGCS expression was
observed (Fig. 3C). ABCA1 expression was significantly increased after KK174 treatment, and a trend was observed
for KK175 (Fig. 3D). Although neither compound increased ABCA1 expression as robustly as the LXR agonist
T0901317, these results indicate that these probes, in contrast to LKM38 and trans-sterol, directly activate LXR.
Localization of lipoprotein-derived diazirine alkyne probe
Based on the results in cholesterol auxotrophy and
SREBP2 target gene expression assays, LKM38 was selected
for further characterization. Cholesterol and cholesteryl
ester-laden lipoprotein particles enter the cell through receptor-mediated endocytosis and then transit through the
endocytic pathway to reach the lysosomal compartment.
To assess whether diazirine alkyne probes trafficked in a
similar manner, acLDL reconstituted with LKM38 oleate
was delivered to U2OS-SRA cells. Click addition of azidefluorophore allowed for the visualization of the cellular
distribution of the probe. In the presence of an LAL inhibitor (LALi) that prevents the cleavage of cholesteryl esters
to free cholesterol, punctate probe staining was observed
(Fig. 4A). The probe signal colocalized with LysoTracker
Red DND-99, a selective marker for acidic organelles, with

a Pearson’s coefficient of 0.6788 (Fig. 4B). In the absence
of LALi, both punctate and reticular staining patterns were
observed, and LysoTracker colocalization was attenuated
(Pearson’s coefficient: 0.4780). Thus, when provided as an
ester in lipoprotein particles, LKM38 accumulates in lysosomes, and the action of LAL is required for trafficking to
other cellular compartments, similar to native cholesterol.
Postlysosomal distribution of diazirine alkyne probe
From the lysosome, cholesterol is distributed to other
cellular compartments, including the ER and plasma membrane. To evaluate the fidelity of trafficking of the diazirine
alkyne probe, the kinetics of probe arrival at these compartments was compared with deuterated cholesterol using
LC/MS/MS-based biochemical trafficking assays. LKM38
oleate or d7-cholesteryl oleate was reconstituted in acLDL
particles and delivered to U2OS-SRA cells in the presence
of LALi (Fig. 5A). Cholesterol or probe metabolites were
collected at several points after LALi washout. By supplying
d9-oleate, the formation of a differentially deuterated reesterification product (d9-LKM38 oleate or d16-cholesteryl
oleate) was used to monitor probe arrival at the ER. Arrival
at the plasma membrane was determined using a cholesterol oxidase assay and quantification of oxidized derivatives (LKM38-one or d7-cholestenone). The difference in
Probes for intracellular cholesterol trafficking
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Fig. 3. Diazirine alkyne probes regulate cholesterol homeostasis. U2OS-SRA cells (A, B) or CYP27A1-deficient
human skin fibroblasts (C, D) were treated for 14 h in starvation media containing 10 M probe or cholesterol in ethanol. HMGCS (A, C) and ABCA1 (B, D) mRNA expression was determined by qPCR relative to
Rplp0. The LXR agonist T0901317 (T-cmpd) is shown as a positive control. Values are normalized to vehicle.
Bars: mean + SEM, n = 5 (A, B) or n = 3 (C, D). ****P < 0.0001, ***P < 0.001, **P < 0.01, and *P < 0.05 for
comparisons indicated using one-way ANOVA followed by Dunnett’s test.
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the amount of LKM38 oleate and d7-cholesteryl oleate
loaded to cells was not statistically significant (Fig. 5B).
After inhibitor washout, LAL cleaved LKM38 oleate and
d7-cholesteryl oleate with similar kinetics. Re-esterification
products were detected for both LKM38 and d7-cholesterol
(Fig. 5C). Significantly more LKM38 was re-esterified relative to d7-cholesterol. At early time points, LKM38 and
d7-cholesterol arrival at the plasma membrane was nearly
identical; however, LKM38, in contrast to cholesterol,
failed to continue to accumulate in the plasma membrane
past 6 h (Fig. 5D). Together, these data suggest structural
modifications present in the LKM38 diazirine alkyne probe
do not affect sterol trafficking to the plasma membrane at
short time points but do increase reesterification.
Protein labeling by the diazirine alkyne probe
The diazirine modification to the sterol structure of
LKM38 permits the cholesterol probe to be UV-crosslinked to molecules in close proximity. To test this functionality and to assay the probe interactome, we evaluated
LKM38 labeling of structurally diverse, established cholesterol binding proteins, NPC1, NPC2, and caveolin. Following labeling, incubation with probe, and UV cross-linking,
target proteins were immunoprecipitated from labeled
lysates using the respective antibody, subjected to click addition of a fluorescein azide, separated by SDS-PAGE, and
then imaged. LKM38 labeled endogenously expressed
NPC1 and caveolin (Fig. 6A, C) and epitope-tagged NPC2
(Fig. 6B), as evidenced by the fluorescent signal at the appropriate molecular weight in the immunoprecipitates.
When labeling was performed in the presence of increasing amounts of excess free cholesterol or in the presence of
712
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acLDL as a competitor, probe binding was diminished.
Specific binding of LKM38 has previously been reported
for the CRAC/CARC domain-containing protein SLC38A9
(17). Importantly, LKM38 failed to label VAMP7, an abundant transmembrane endolysosomal protein that has not
been previously identified as interacting with cholesterol
(Fig. 6D) (27). In order to obtain a broader view of the
LKM38 interactome, total protein lysate was visualized after labeling with LKM38. Many fluorescent bands were
identified, indicating that LKM38 has a large interactome
(Fig. 7A). To test specificity, excess cholesterol, in the form
of acLDL, was included after probe incubation. AcLDL
incubation led to the reduced labeling of many of these
species, suggesting these interactions are specific (Fig. 7B).

DISCUSSION
Intracellular cholesterol trafficking is widely studied but
remains poorly understood. Diazirine alkyne probes provide a new approach for the study of intracellular cholesterol distribution using a variety of techniques, including
immunofluorescence microscopy, MS-based biochemical
trafficking, and proteomics. In this study, we synthesized
and characterized novel diazirine alkyne probes and investigated their fidelity as cholesterol mimics. Probes were designed with diazirine alkyne functional modifications
located at different points on the sterol backbone to identify the least perturbing set of modifications. Novel probes
were compared with the commercially available diazirine
alkyne probe trans-sterol. Prior characterization of transsterol, LKM38, and KK174 has been limited to protein

Downloaded from www.jlr.org at Washington Univ Medical Library, on December 4, 2019

Fig. 4. LKM38 oleate localizes to the lysosomal compartment. U2OS-SRA cells were incubated in LPDM containing 50 g/ml acLDL
reconstituted with LKM38 oleate, labeled with lysotracker, and fluorescently labeled using copper-catalyzed azide alkyne cycloaddition of
Alexa-488. A: Images collected by laser-scan confocal microscopy. B: Colocalization quantification. Pearson coefficients were calculated for
6–10 fields/condition/per experiment using ImageJ. Each data point represents the average Pearson coefficient for a biologically independent sample, n = 3. Bars: mean + SEM. *P < 0.05 using t-test.
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binding studies with nonphysiological probe delivery
(16, 17). The results presented here are the first assessment of the ability of diazirine alkyne probes to support
cell growth in the absence of cholesterol and to report on
the interactions and trafficking itinerary of probe that is
presented to cells in the context of lipoprotein particles.
Multiple readouts of cholesterol’s function were used to
compare the ability of the different probes to mimic cellular functions of cholesterol. SREBP-regulated responses
rely primarily on the behavior of the sterol in the ER membrane and can serve as sensitive readouts of cholesterol
function in this organelle. LKM38 and trans-sterol similarly suppressed transcription of an SREBP target gene in
the absence of off-target oxysterol transcriptional effects.
We also tested for the ability of probes to support the
growth of cholesterol-auxotrophic cells, a more rigorous
test of cholesterol mimicry that relies on the ability of the
probe to serve as the sole sterol source in the cell and assume all of the cellular functions of cholesterol. Of the
diazirine alkyne probes evaluated, only LKM38 was able to
sustain the growth of cholesterol-auxotrophic cells, and
trans-sterol was cytotoxic in this assay. We hypothesize that
the position of the diazirine on the trans-sterol probe and/
or side-chain modifications may have prevented sterol-protein interactions required for cellular functions beyond
the SREBP system. Based on these findings, LKM38 was
selected for further evaluation as a cholesterol trafficking
mimic.
Biochemical trafficking experiments allowed for the
characterization of the postlysosomal trafficking of probe.

Esterification of the LKM38 probe was more robust than
for d7-cholesterol. Increased esterification of LKM38 could
be an indication of increased delivery to the ER compartment or increased ACAT activity, possibly due to increased
membrane availability (28, 29). Trafficking of LKM38 to
the plasma membrane was essentially identical to native
cholesterol trafficking to this compartment at early time
points. Divergence at longer time points could be due to
increased availability in the plasma membrane or an inability of LKM38 to recycle back to this compartment. Together, these data indicate that LKM38 is a useful probe for
studying the postlysosomal cholesterol trafficking to the
plasma membrane, but a bias of LKM38 toward lipid droplets should be considered when using this probe as a postlysosomal cholesterol trafficking tool. Increased association
of a commonly used fluorescent cholesterol conjugate,
BODIPY-cholesterol, with lipid droplets has also been observed (30).
Alkyne modification to the backbone structure of diazirine alkyne probes provides a highly flexible approach
for the study of molecular distribution by fluorescence microscopy. The alkyne group is a minor modification that
does not greatly influence the character of the molecule,
as evidenced by the ability of a variety of alkyne cholesterol
probes to support the growth of cholesterol-auxotrophic
cells to nearly the same degree as cholesterol. Unlike the
intrinsic fluorescent cholesterol probes, such as dehydroergosterol and cholestatrienol, which have low quantum
yields, the click chemistry-compatible alkyne group of diazirine alkyne probes allows for the addition of a strong,
Probes for intracellular cholesterol trafficking
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Fig. 5. LKM38 traffics to the plasma membrane and ER compartments. A: U2OS-SRA cells were treated with LPDM containing 50 g/ml
acLDL reconstituted with d7-cholesteryl oleate or LKM38 oleate in the presence of LALi to load the lysosomal compartment and chased in
LALi-free media for 0–12 h to allow sterol trafficking. B: Chase media contained d9-oleate/BSA to label newly synthesized esters. C: Cells
were fixed and then treated with cholesterol oxidase before cellular lipids were extracted. d7-Cholesteryl oleate or LKM38 oleate (B), d16cholesteryl oleate or d9-LKM38 oleate (C), and cholestenone or LKM38-one (D) were quantified by LC/MS/MS. Bars: mean + SEM, n = 3.
*P < 0.01 using multiple t-tests with a false discovery rate of 1%.
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Fig. 6. LKM38 specifically labels established cholesterol binding proteins. Normal human skin fibroblasts (A), NPC2-HA (B), or U2OSSRA (C–E) cells were treated with 2.5 (A) or 10 M (B–D) probe complexed to methyl--cyclodextrin without (1:0) or with 10× (1:10) or
100× (1:100) cholesterol or acLDL as competitor and cross-linked. Immunoprecipitated protein (IP) was clicked to rhodamine X azide before elution in sample buffer and separation by SDS-PAGE. Gels were imaged at 610 nm then transferred to nitrocellulose for Western blotting (WB) for NPC1 (160 kDa), NPC2 (23 and 20 kDa), caveolin (20 kDa), and VAMP7 (25 kDa). Bars: mean + SEM, n = 3. ****P < 0.0001,
***P < 0.001, **P < 0.01, and *P < 0.05 for comparisons indicated using paired two-tailed t-test.

photostable fluorescent azide (of which there are many
commercially available) to be added after trafficking
has taken place. This approach is compatible with fixed
cell imaging to visualize static cholesterol distribution,
similar to the prior use of a C19-alkyne cholesterol (31).
By using a targeted lipoprotein delivery system and the
alkyne functionality of diazirine alkyne probes, we were
714

Journal of Lipid Research Volume 60, 2019

able to monitor the dynamic redistribution of cholesterol
from the lysosome to the rest of the cell using confocal
microscopy.
The cross-linking functionality of diazirine alkyne probes
enables the study of probe-protein interactions, which are
not possible with BODIPY-cholesterol and dehydroegosterol. We demonstrated binding for LKM38 to NPC1,
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NPC2, and caveolin and have previously reported binding
to the CRAC/CARC domain-containing protein SLC38A9
(17). These interactions are specific, as each was sensitive
to cholesterol competition. These proteins represent four
structurally distinct cholesterol-binding motifs. The ability
of LKM38 to bind specifically to structurally diverse proteins with distinct cholesterol binding motifs has the potential to expand the interactome accessible for study using
this technique. While these experiments were based on the
fluorescent detection of labeled targets, click addition of
different azide handles allows for the enrichment of labeled proteins for MS-based protein identification. Such
an approach was used for trans-sterol, a commercially available diazirine alkyne cholesterol probe (15); however,
trans-sterol did not identify NPC2 or label NPC1 in a cholesterol-specific manner. Our data suggest that the structure of LKM38 has the potential to serve as a more sensitive
and biologically relevant cholesterol probe.
In summary, we have characterized the authenticity of
diazirine alkyne probes as cholesterol mimics using a variety of cell biological approaches. LKM38 emerged as a
high-fidelity cholesterol mimic through its ability to sustain
growth in auxotrophic cells and appropriately regulate
cholesterol homeostasis. Moreover, through biochemical
trafficking assays and immunofluorescence microscopy, we
showed that lysosomally derived LKM38 is distributed to
the plasma membrane and ER, providing evidence that
this probe is suitable for trafficking studies. Finally, we
demonstrated specific cholesterol-protein interactions between LKM38 and known cholesterol binding proteins.

Taken together, these findings validate LKM38 as a flexible
tool for the study of intracellular cholesterol trafficking.
The authors thank Hideji Fujiwara for advice regarding cholestenone
derivatization.
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